Assignee
GENOME & COMPANY
KR·7 granted patents·10 pending applications·0 citations·filing 2018–2022
Top patents by PatentIndex Score
17 records- 0178US11453857B2Lactobacillus fermentum LM1016 strain (KCCM12468P)GENOME & COMPANY·Filed 2019·Granted Sep 27, 2022·0 cites·10 claims
- 0268US11571448B2Lactobacillus rhamnosus LM1019 strain and composition for preventing and treating obesity or diabetes mellitus comprising sameGENOME & COMPANY·Filed 2018·Granted Feb 7, 2023·0 cites·11 claims
- 0363US2023055117A1Novel Lactobacillus Fermentum LM1016 Strain, And Composition For Preventing Or Treating Cardiovascular DiseasesGENOME & COMPANY·Filed 2022·Application pending·0 cites
- 0461US11478513B2Cutibacterium avidum strain, and composition for preventing or treating atopic dermatitis, comprising strain or cultured product thereofGENOME & COMPANY·Filed 2019·Granted Oct 25, 2022·0 cites·11 claims
- 0560US11406589B2Cutibacterium granulosum strain, and composition comprising such strain or culture thereof for preventing or treating acneGENOME & COMPANY·Filed 2019·Granted Aug 9, 2022·0 cites·4 claims
- 0656US12214004B2Strains having effects of preventing or treating cancersGENOME & COMPANY·Filed 2020·Granted Feb 4, 2025·0 cites·17 claims
- 0754US12564613B2Strains having effects of preventing or treating cancersGENOME & COMPANY·Filed 2019·Granted Mar 3, 2026·0 cites·5 claims
- 0854US2024182563A1Anti-cntn4 antibody and use thereofGENOME & COMPANY·Filed 2022·Application pending·0 cites
- 0952US2025120903A1Novel sphingomonas paucimobilis strain and use thereofGENOME & COMPANY·Filed 2022·Application pending·0 cites
- 1051US2025017987A1NOVEL STRAIN of LACTOBACILLUS PLANTARUM AND USE THEREOFGENOME & COMPANY·Filed 2022·Application pending·0 cites
- 1149US2024209112A1Anti-bcam antibody or antigen-binding fragment thereofGENOME & COMPANY·Filed 2021·Application pending·0 cites
- 1245US2024209081A1Anti-cntn4-specific antibodies and use thereofGENOME & COMPANY·Filed 2021·Application pending·0 cites
- 1343US11787870B2Pharmaceutical composition for preventing or treating cancer comprising LRIT2 inhibitor as active ingredientGENOME & COMPANY·Filed 2019·Granted Oct 17, 2023·0 cites·10 claims
- 1439US2022387522A1Composition for enhancing or improving immune system comprising bifidobacterium bifidumGENOME & COMPANY·Filed 2020·Application pending·0 cites
- 1533US2019310261A1Novel target for anti-cancer and immune-enhancingGENOME & COMPANY·Filed 2019·Application pending·0 cites
- 1633US2019216840A1Novel use of kirrel2 and kirrel2 inhibitorGENOME & COMPANY·Filed 2019·Application pending·0 cites
- 1733US2021115139A1Pharmaceutical composition for preventing or treating cancer, containing cd300e inhibitor as active ingredientGENOME & COMPANY·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENOME & COMPANY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →